Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced that Daniel Grau, CEO and President, will present at the upcoming Guggenheim Targeted Protein Degradation Day at 2:00PM – 2:30PM on Wednesday, March 16, 2022.
March 14, 2022
· 1 min read